| KHC |
Report |
Organic Net Sales Growth (Q2 2026) |
IN-LINE |
pred ~-3.5% vs. cons -3.6% |
MEDIUM |
| KHC |
Report |
Adj. Gross Profit (Q2 2026) |
MISS |
pred ~$2,040M vs. cons $2,051M |
MEDIUM |
| KHC |
Report |
Adj. EPS Diluted (Q2 2026) |
BEAT |
pred ~$0.545 vs. cons $0.528 |
HIGH |
| KHC |
Guide |
FY2026 Organic Growth (FY2026) |
LOWER |
guide ~-2.5% midpoint vs. cons -1.95% |
HIGH |
| KHC |
Guide |
FY2026 Adj. EPS (FY2026) |
LOWER |
guide ~$2.04 midpoint vs. cons $2.07 |
HIGH |
| KHC |
Guide |
FY2026 Adj. Gross Margin (FY2026) |
UNCHANGED |
guide -25 to -75bps maintained vs. cons in-line |
MEDIUM |
| KHC |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
MEDIUM |
| KHC |
Return |
5-day cumulative residual |
-4.0% (FADE) |
FADE — Archetype C: H2 estimate cuts as sell-side resets to guide midpoints; short covering limits but does not reverse the drift |
MEDIUM |